Pfizer's inclacumab fails Phase III study for sickle cell disease, disappointing the community while the company remains ...

Eli Lilly will raise UK list prices for its Mounjaro weight-loss jab by as much as 170% from September after Donald Trump ...

When ideology overtakes pragmatism in crafting public policies, it portends danger to society. The recent decision by the ...